Zoetis Inc. (ZTS)’s financial ratios: A comprehensive overview

Zoetis Inc. (NYSE: ZTS) closed the day trading at $172.67 down -3.82% from the previous closing price of $179.52. In other words, the price has decreased by -$6.85 from its previous closing price. On the day, 2301728 shares were traded. ZTS stock price reached its highest trading level at $177.98 during the session, while it also had its lowest trading level at $171.40.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.



For a better understanding of ZTS, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 37.94 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 96.58. For the most recent quarter (mrq), Quick Ratio is recorded 1.90 and its Current Ratio is at 3.30. In the meantime, Its Debt-to-Equity ratio is 1.46 whereas as Long-Term Debt/Eq ratio is at 1.46.

Upgrades & Downgrades

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 18 when Lagano Roxanne sold 4,338 shares for $175.94 per share. The transaction valued at 763,228 led to the insider holds 26,357 shares of the business.

Lagano Roxanne sold 13,010 shares of ZTS for $2,276,750 on Feb 14. The Executive Vice President now owns 26,357 shares after completing the transaction at $175.00 per share. On Jul 22, another insider, Lagano Roxanne, who serves as the Executive Vice President of the company, sold 2,167 shares for $180.26 each. As a result, the insider received 390,623 and left with 23,687 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZTS now has a Market Capitalization of 86.06B and an Enterprise Value of 90.70B. As of this moment, Zoetis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 39.00, and their Forward P/E ratio for the next fiscal year is 28.45. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.51. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.87 while its Price-to-Book (P/B) ratio in mrq is 17.80. Its current Enterprise Value per Revenue stands at 11.21 whereas that against EBITDA is 27.25.

Stock Price History:

Over the past 52 weeks, ZTS has reached a high of $187.82, while it has fallen to a 52-week low of $124.15. The 50-Day Moving Average of the stock is 173.20, while the 200-Day Moving Average is calculated to be 160.62.

Shares Statistics:

Over the past 3-months, ZTS traded about 1.81M shares per day on average, while over the past 10 days, ZTS traded about 1.62M shares per day. A total of 463.50M shares are outstanding, with a floating share count of 461.18M. Insiders hold about 0.20% of the company’s shares, while institutions hold 94.50% stake in the company. Shares short for ZTS as of Apr 27, 2023 were 4.55M with a Short Ratio of 4.55M, compared to 5.07M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 0.98% and a Short% of Float of 0.99%.

Dividends & Splits

ZTS’s forward annual dividend rate is 1.50, up from 1.35 a year ago. Against a Trailing Annual Dividend Yield of 0.75%, it implies a Forward Annual Dividend Yield of 0.84%. The stock’s 5-year Average Dividend Yield is 0.58.

Earnings Estimates

Current recommendations for the stock of the company come from 11 analysts. On average, analysts expect EPS of $1.32 for the current quarter, with a high estimate of $1.36 and a low estimate of $1.26, while EPS last year was $1.2. The consensus estimate for the next quarter is $1.38, with high estimates of $1.42 and low estimates of $1.35.

Analysts are recommending an EPS of between $5.47 and $5.34 for the fiscal current year, implying an average EPS of $5.4. EPS for the following year is $6.07, with 13 analysts recommending between $6.58 and $5.8.

Revenue Estimates

10 analysts predict $2.17B in revenue for the current quarter. It ranges from a high estimate of $2.19B to a low estimate of $2.1B. As of the current estimate, Zoetis Inc.’s year-ago sales were $2.05B, an estimated increase of 5.70% from the year-ago figure. For the next quarter, 10 analysts are estimating revenue of $2.2B, an increase of 5.60% less than the figure of $5.70% in the same quarter last year. There is a high estimate of $2.23B for the next quarter, whereas the lowest estimate is $2.17B.

A total of 12 analysts have provided revenue estimates for ZTS’s current fiscal year. The highest revenue estimate was $8.7B, while the lowest revenue estimate was $8.57B, resulting in an average revenue estimate of $8.63B. In the same quarter a year ago, actual revenue was $8.08B, up 6.80% from the average estimate. Based on 12 analysts’ estimates, the company’s revenue will be $9.29B in the next fiscal year. The high estimate is $9.68B and the low estimate is $9.05B. The average revenue growth estimate for next year is up 7.60% from the average revenue estimate for this year.